Vrtx stock price.

AIG Stock Price Prediction 2023, 2024, 2025: AIG Gaining Pace Post Q3 Results. November 7, 2023 7:33 pm EST. stock. VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move. November 7, 2023 7:05 pm EST. stock. WBI Share Price Crashes Below 1 GBX, Analysts Hope For A Recovery.

Vrtx stock price. Things To Know About Vrtx stock price.

Vertex currently has an average brokerage recommendation (ABR) of 1.59, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc ...Oct 2, 2023 · The lower the Forward P/E, the cheaper the stock. VRTX’s price/book is 5.96. Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on ... Nov 24, 2023 · Analyzing VRTX Stock Performance. On Wednesday, Vertex Pharmaceuticals, Inc. [NASDAQ: VRTX] plunged -0.44% to $353.23. The stock’s lowest price that day was $350.0269, but it reached a high of $358.50 in the same session. During the last five days, there has been a surge of approximately 1.11%. Latest Vertex Pharmaceuticals Inc (VRTX:NSQ) share price with interactive ... VRTX:VIEVienna Stock Exchange; United Kingdom; 0QZU:LSELondon Stock Exchange ...Jun 15, 2021 · The stock price of Vertex Pharmaceuticals (NASDAQ: VRTX) has seen an 8.1% drop over the last five trading days, after the company announced that it will discontinue the clinical trials for VX-864 ...

Vertex Pharmaceuticals (VRTX) closed at $313.57 in the latest trading session, marking a +0.56% move from the prior day. This change outpaced the S&P 500's 0.07% loss on the day.

The target price for VRTX stock is $399.46 based on the average of what a group of analyst think VRTX stock could be worth at a future date. This is not a prediction by Public.com How to buy VRTX stock on Public

Abrahams has a sector perform rating on VRTX stock, but raised his price target to 343 from 325. ... VRTX stock analysts had predicted adjusted earnings of $14.56 per share and $9.76 billion in sales.According to 25 stock analysts, the average 12-month stock price forecast for VRTX stock stock is $372.96, which predicts an increase of 6.21%. The lowest target is $245 and the highest is $456. On average, analysts rate VRTX stock stock as a buy.Vertex Pharmaceuticals Incorporated’s ( VRTX) price is currently down 3.53% so far this month. During the month of November, Vertex Pharmaceuticals Incorporated’s stock price has reached a high of $387.42 and a low of $348.54. Over the last year, Vertex Pharmaceuticals Incorporated has hit prices as high as $387.42 and as low as $282.21.Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, historical performance, charts, and other financial information to help you make more informed …

For example, the Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) share price is up 90% in the last 5 years, clearly besting the market return of around 56% (ignoring dividends).

Mar 20, 2023 · Click here to see why VRTX stock is a Buy. ... The stock price has ranged from a 52-week low of $233.01 to a 52-week high of $325.19. Vertex closed on March 17, 2023, at $295.77. That gave it a PE ...

VRTX - Vertex Pharmaceuticals, Inc. - Stock screener for investors and traders, financial visualizations.The latest closing stock price for Vertex Pharmaceuticals as of November 30, 2023 is 354.81. The all-time high Vertex Pharmaceuticals stock closing price was 385.76 on November 06, 2023. The Vertex Pharmaceuticals 52-week high stock price is 387.42, which is 9.2% above the current share price. The Vertex Pharmaceuticals 52-week low stock price ... It must be understood that any failure of clinical trials of drugs from the pipeline can lead to a drop in the company stock price. However, VRTX's cash position of 14% of its market cap will help ...Vertex Pharmaceuticals Incorporated Common Stock (VRTX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. According to 17 Wall Street analysts that have issued a 1 year VRTX price target, the average VRTX price target is $380.77, with the highest VRTX stock price ...

Vertex Pharmaceuticals stock is buoyed by recent approval of Kalydeco for an additional indication.Vertex Pharmaceuticals Incorporated Common Stock (VRTX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. VRTX stock is another top-rated biotech stock with a strong buy rating from analysts. Wit a price target of $398.93, it shows a gain of more than 45% from the stock’s current price.VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move. November 7, 2023 7:05 pm EST. stock. WBI Share Price Crashes Below 1 GBX, Analysts Hope For A Recovery. November 7, 2023 6:33 pm EST. stock. LRCX Stock Price Prediction 2023-25: Is LRCX Ready to Outperform?Vertex Pharmaceuticals stock is buoyed by recent approval of Kalydeco for an additional indication.

Current. $3.81. 1 Month Ago. $3.83. 3 Months Ago. $3.76. Vertex Pharmaceuticals Inc. analyst estimates, including VRTX earnings per share estimates and analyst recommendations.

Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Complete Vertex Pharmaceuticals Inc. stock information by Barron's. View real-time VRTX stock price and news, along with industry-best analysis. Webull offers VRTX Ent Holdg (VRTX) historical stock prices, in-depth market analysis, NASDAQ: VRTX real-time stock quote data, in-depth charts, free VRTX ...Vertex Pharmaceuticals' CEO is Reshma Kewalramani, appointed in Apr 2020, has a tenure of 3.58 years. total yearly compensation is $15.86M, comprised of 8.8% salary and 91.2% bonuses, including company stock and options. directly owns 0.044% of the company’s shares, worth $39.89M. The average tenure of the management team and the board of ...Dec 4, 2023 · GSK currently has a forward P/E ratio of 9.38, while VRTX has a forward P/E of 23.29. We also note that GSK has a PEG ratio of 1.74. This metric is used similarly to the famous P/E ratio, but the ... Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move. November 7, 2023 7:05 pm EST. stock. WBI Share Price Crashes Below 1 GBX, Analysts Hope For A Recovery. November 7, 2023 6:33 pm EST. stock. LRCX Stock Price Prediction 2023-25: Is LRCX Ready to Outperform?VRTX is the utility token of Vertex Protocol. There will only be 1 billion total VRTX. Staking VRTX generates voVRTX, a non-transferable user metric which signals long-term commitment and participation in the exchange. voVRTX scores will be used to determine rewards to users. Over extended durations, users who demonstrate a long …At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Vertex Pharmaceuticals (VRTX) closed at $313.57 in the latest trading session, marking a +0.56% move from the prior day. This change outpaced the S&P 500's 0.07% loss on the day.

Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.

Conversely, if more people wanted to sell a stock than buy it, there would be greater supply than demand, and the price would fall. VRTX 354.81 +3.81(1.09%) Will VRTX be a Portfolio Killer in ...The biopharmaceutical company has multiple catalysts that could boost its share price further. Vertex Pharmaceuticals ( VRTX -0.16% ) is a lower-risk biotech stock to consider, as well.The latest Vertex Pharmaceuticals stock prices, stock quotes, news, and VRTX history to help you invest and trade smarter.The company’s stock jumped 7.9% on Monday, as the investors cheered the FDA’s Orphan Drug Designation to ARCT-032 for the CF indication. Year to date, shares of ARCT have surged 52.1% against ...The live Vertex Protocol price today is $0.4411 USD with a 24-hour trading volume of $2,773,353.15 USD. We update our VRTX to USD price in real-time.Get the latest Vertex Pharmaceuticals Incorporated (VRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ... Price Targets are an analyst's best guess at where the stock will trade in 12 months. ... The current price Vertex Pharmaceuticals (VRTX) is trading at is $351.16, ...Vertex Pharmaceuticals Incorpor (VRTX) stock forecast and price target. Find the latest Vertex Pharmaceuticals Incorpor VRTX analyst stock forecast, price target, and recommendation trends with in ... What is Vertex Pharmaceuticals Inc (VRTX)'s stock price today? The current price of VRTX is $353.26. The 52 week high of VRTX is $387.42 and 52 week low is $282.21. When is next earnings date of Vertex Pharmaceuticals Inc (VRTX)? The next earnings date of Vertex Pharmaceuticals Inc (VRTX) is 2024-02-07 Est..Insider Sell Alert: EVP and CMO Carmen Bozic Sells 5,650 Shares of Vertex Pharmaceuticals Inc (VRTX) (GuruFocus.com) Nov-16-23 07:05PM. Analyst Report: Vertex Pharmaceuticals Incorporated. (Morningstar Research) 04:06PM. Market Today: CRISPR Therapeutics and Vertex Pharmaceuticals Make History with UK Drug Approval.Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...

VRTX | Complete Vertex Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Vertex Pharmaceuticals (VRTX) closed at $317.27 in the latest trading session, marking a -1.8% move from the prior day. This change lagged the S&P 500's 1.05% gain on the day. Elsewhere, the Dow ...Future criteria checks 2/6. Vertex Pharmaceuticals is forecast to grow earnings and revenue by 10.4% and 8% per annum respectively. EPS is expected to grow by 10.2% per annum. Return on equity is forecast to be 32.8% in 3 years.Instagram:https://instagram. target wd40farmland etfsoxcl stockis meet beagle safe Price as of December 1, 2023, ... Vertex Pharmaceuticals (VRTX 0.15%) and CRISPR Therapeutics (CRSP 0.99%) ... And that could boost the stock over the long term.Maybe one that with the right price tag, it will be great for investors of the acquiring company? Brian Orelli: Maybe every biotech in my portfolio, I'd love for each and every one of them to be ... schwab private client servicesjf kennedy coins value Vertex Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ... Stock Price Target VRTX. High $ 456.00: Median $ 394.00: Low $ 325.00: Average $ 399.46 ... Dec 1, 2023 · 19 brokers have issued 12-month price targets for Vertex Pharmaceuticals' shares. Their VRTX share price targets range from $296.00 to $456.00. On average, they expect the company's stock price to reach $376.13 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View analysts price targets for VRTX or view ... nysearca iwy VRTX Stock Price Prediction 2023, 2024, 2025: VRTX Delivers Sensational Move - November 7, 2023 7:05 pm EST; Palantir Technology Price Prediction 2023-2025: Can It Rise More? - November 7, 2023 3:02 pm EST; Leave a Reply Cancel reply. Your email address will not be published. Required fields are marked * Comment *Shares of Vertex Pharmaceuticals (VRTX-0.05%) ... Vertex's future looks a little brighter than its stock price suggests. Shares are currently trading at around 23.1 times last year's earnings.